A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada

Medical Care - Tập 54 Số 1 - Trang 98-105 - 2016
Feng Xie1,2,3, Eleanor Pullenayegum4, Katherine Gaebel5,1,6,7,8,9, Nick Bansback10, Stirling Bryan10, Arto Öhinmaa11, Lise Poissant12, Jeffrey Johnson11
1Department of Clinical Epidemiology and Biostatistics, McMaster University
2Father Sean O’Sullivan Research Centre, St. Joseph’s Healthcare, Hamilton
3Program for Health Economics and Outcome Measures (PHENOM)
4Child Health Evaluative Sciences Group, Hospital for Sick Kids, Toronto, ON
5Coinvestigators: Drs N. Bansback, S. Bryan (University of British Columbia), A. Ohinmaa (University of Alberta), L. Poissant (University of Montreal), E. Pullenayegum (Hospital for Sick Children)
6Research Assistants: Samantha Pollard and Lidia Engel (University of British Columbia)
7Research Coordinator: Kathy Gaebel (McMaster University)
8Serena Humphries and Fatima Al Sayah (University of Alberta), Touria Addou (University of Montreal).
9The Canadian EQ-5D-5L Valuation Study Group: Principal Investigators: Drs F. Xie (McMaster University) and J.A. Johnson (University of Alberta)
10School of Population and Public Health, University of British Columbia, Vancouver, BC
11School of Public Health, University of Alberta, Edmonton, AB
12School of Medicine, Université de Montréal, Montreal, QC, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Brooks, 1996, EuroQol: the current state of play., Health Policy, 37, 53, 10.1016/0168-8510(96)00822-6

Brauer, 2006, . Trends in the measurement of health utilities in published cost-utility analyses., Value Health, 9, 213, 10.1111/j.1524-4733.2006.00116.x

Herdman, 2011, . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)., Qual Life Res, 20, 1727, 10.1007/s11136-011-9903-x

Bansback, 2012, . Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies., PLoS One, 7, e31115, 10.1371/journal.pone.0031115

Oppe, 2014, Devlin NJ, van HB, et al.. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol., Value Health, 17, 445, 10.1016/j.jval.2014.04.002

Janssen, 2013, . Introducing the composite time trade-off: a test of feasibility and face validity., Eur J Health Econ, 14, S5, 10.1007/s10198-013-0503-2

Dolan, 1997, Modeling valuations for EuroQol health states., Med Care, 35, 1095, 10.1097/00005650-199711000-00002

Shaw, 2005, US valuation of the EQ-5D health states: development and testing of the D1 valuation model., Med Care, 43, 203, 10.1097/00005650-200503000-00003

Thông tin
Thông tin xuất bản

Medical Care

Tập 54 Số 1

98-105

Thông tin tác giả